Pathogenesis of diabetic vascular disease: Evidence for the role of reduced heparan sulfate proteoglycan

Diabetes

Volumn 46, Issue SUPPL. 2, 1997, Pages

  Jensen, Tonny ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARIN; PROTEOHEPARAN SULFATE;

ATHEROSCLEROSIS; CONFERENCE PAPER; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; FIBRINOLYSIS; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0030921674     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.s98     Document Type: Conference Paper

References (23)

1. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T: Declining incidence of proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 36:205-209, 1987
2. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985
3. Borch-Johnsen K, Kreiner S: Proteinuria: value as predictor of cardiovascuar mortality in insulin-dependent diabetes mellitus. Br Med J 294:1651-1654, 1987
4. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
5. Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T: Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26:406-410, 1984
6. Jensen T: Albuminuria: a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus. Dan Med Bull 38:134-144, 1991
7. Cohen MP, Klepser H, Wu V-Y: Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition. Diabetes 37:1324-1327, 1988
8. Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M: Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33:100-106, 1988
9. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno Hypothesis. Diabetologia 32:219-226, 1989
10. Castelot JJ, Hoover RL, Harper PA, Karnovsky MJ: Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation. Am J Pathol 120:427-435, 1985
11. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM: Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 41:1070-1080, 1992
12. Tamsma JT, van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes HHPJ, van der Woude FJ: Expression of glomerular extracellular matrix components in diabetic nephropathy: decrease of heparan sulfate in the glomerular basement membrane. Diabetologia 37:313-320, 1994
13. Nugent MA, Karnovsky MJ, Edelman ER: Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. Circ Res 73:1051-1060, 1993
14. Dybdahl H, Ledet T: Diabetic microangiopathy: quantitative histopathological studies of the extramural coronary arteries from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 30:882-886, 1987
15. Wasty F, Alavi MZ, Moore S: Distribution of glycosaminoglycans in the intima of human aorta: changes in atherosclerosis and diabetes mellitus. Diabetologia 36:316-322, 1993
16. Kjellen L, Bielefeld D, Hook M: Reduced sulfatation of liver heparan sulfate in experimentally diabetic rats. Diabetes 32:337-342, 1983
17. Kofoed-Enevoldsen A: Inhibition of glomerular glucosaminyl N-deacetylase in diabetic rats. Kidney Int 41:763-767, 1992
18. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527, 1992
19. Hansen PM, Jensen JS, Pociot F, Deckert T: Possible association between genetic variation in the perlecan gene and urinary albumin excretion (Abstract). Diabetologia 38 (Suppl. 1):A229, 1995
20. Sandeman DD, Shore AC, Tooke JE: Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 327:760-764, 1992
21. Gambaro G, Cavazzana AO, Luzi P, Piccolo A, Borsatti A, Crepaldi G, Marchi E, Venturini AP, Baggio B: Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 42:285-291, 1992
22. Gambaro G, Venturine AP, Noonan DM, Fries W, Re G, Garbisa S, Milanesi C, Pesarini A, Borsatti A, Marchi E, Baggio B: Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 46:797-806, 1994
23. Myrup B, Hansen PM, Jensen T, Kofoed-Enevoldsen A, Feldt-Rasmussen B, Gram J, Kluft C, Jespersen J, Deckert T: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 345:421-422, 1995